- Home
- NEWS
- REGIONAL
- THIS WEEK'S PAPER
- BLOGS
- Multimedia
- OPINION
- A&E
- LISTS
- PEOPLE
- EVENTS
- Classifieds
- Subscribe
Health Care Businesses
Arcadia: Don't buy our stock
March 5, 2012
J.K. WallArcadia Resources Inc. is telling shareholders not to buy its stock because it is out of cash and faces a $40 million pile
of debt that comes due on April 1.
MoreFDA removes hurdle in Endocyte's path to drug approval
March 5, 2012
J.K. WallEndocyte Inc. can start enrolling patients again in a clinical trial of its experimental cancer drug, the company announced
Monday, clearing away a hurdle to getting the drug approved in Europe.
MoreAnthem seeking state rule change allowing doctors to practice online
March 3, 2012
J.K. WallAnthem Blue Cross and Blue Shield has renewed its push to bring online care to the Indiana market, including video. It has
asked the state’s Medical Licensing Board to relax a 2003 rule that stands in its way.
MoreNew drugmaker code deprives docs of football, lunch for 2
March 1, 2012
Bloomberg NewsDoctors can still get free samples of medicines, but not football tickets or lunch for their spouses, under a revised code
of conduct drafted by a global drug industry trade group that counts Eli Lilly as a member.
MoreLilly plans 200 jobs at new $440M Ireland plant
February 27, 2012
IBJ Staff and Bloomberg NewsEli Lilly and Co. plans to invest about $440 million in a new pharmaceutical plant at an existing company site in County Cork
in southern Ireland. The facility in Kinsale will require as many as 200 skilled employees when fully operational.
MoreSynCare files anticipated bankruptcy
February 22, 2012
The once fast-growing, Indianapolis-based disease-management company listed in court papers on Tuesday liabilities of nearly
$5.7 million and assets of just $125,864.
MoreEconomy could lift drug, device firms
February 20, 2012
J.K. WallThe U.S. economy is showing signs of bouncing back and, if it does, look for drugmakers and medical-device companies to benefit.
But if the economy has another summer stall like last year, expect health insurers to benefit.
MoreDrugmakers singing same song: 2012 will be tough
February 2, 2012
Associated PressFor drugmakers, the golden era of the 1990s and early part of the last decade, when they seemed to effortlessly churn out
new multibillion-dollar pills for the masses along with double-digit quarterly profit increases, is not even in the rearview
mirror any more.
MoreLilly eying deal with Turkish drug company
January 31, 2012
Bloomberg NewsEli Lilly and Co. is among about a half-dozen companies interested in buying a stake in Mustafa Nevzat Ilac Sanayii AS in
a deal that may value the Turkish drugmaker at $1 billion, sources say.
MoreEli Lilly unit plans to buy feed-enzyme maker
January 24, 2012
Associated PressDrugmaker Eli Lilly and Co.'s Elanco animal health division plans to buy a privately held maker of feed-enzyme products
that improve poultry, egg and meat production.
MoreFrench breast-implant recall could sway U.S. device debate
January 19, 2012
Bloomberg NewsU.S. medical device makers have spent the last year urging government officials to approve high-risk products faster, like
their European counterparts. A scandal over leaking breast implants made in France, however, may make the argument more difficult.
MoreLilly's Zyprexa pact with health providers wins approval
January 12, 2012
Bloomberg NewsEli Lilly and Co. has won approval of a $4.5 million settlement with five union health funds and an insurer that alleged improper
marketing of the company's best-selling medication, Zyprexa, raised their costs.
MoreOnce-rising star AIT Laboratories now cutting jobs
January 11, 2012
Chris O'MalleyAIT Laboratories, one of the area’s fastest-growing companies in recent years, confirmed Tuesday that it is eliminating
jobs, but would not say how many. The company said it is restructuring.
MoreBoston lawsuit claims DES-breast cancer link
January 8, 2012
Associated PressFifty-three women from around the country are suing drug companies, including Eli Lilly and Co., who made and promoted DES
for millions of pregnant women from about 1938 to the early 1970s.
MoreHealthx receives $22M capital infusion
January 6, 2012
Frontier Capital in Charlotte, N.C., provided the funding that will support the continued expansion of Healthx, a local provider
of online health care portals.
MoreLilly's 2012 earnings forecast misses analyst estimates
January 5, 2012
Bloomberg News, Associated PressIndianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a
wide margin, sending shares down.
MoreLilly challenging Biogen patent in London lawsuit
January 5, 2012
Bloomberg NewsEli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system
diseases.
MoreWalgreen expects to lose most Express Scripts biz
December 29, 2011
Associated PressDrugstore operator Walgreen Co. said Thursday it expects to lose almost 90 percent of prescriptions handled by pharmacy benefits
manager Express Scripts Inc. after it leaves Express Scripts' networks on Jan. 1.
MoreEndocyte shares plunge on clinical trial results
December 13, 2011
J.K. WallShares of Endocyte Inc. plummeted more than 60 percent Tuesday morning after clinical trial results showed the company’s
experimental ovarian cancer drug led to shorter survival times than treatment with a standard cancer drug.
MoreLilly shares rise on possibility for Alzheimer’s drug
December 7, 2011
Bloomberg NewsEli Lilly and Co. stock rose to a one-month high Tuesday after an analyst said the possible success of the company’s
experimental Alzheimer’s drug could double the share price.
MoreQ&A
December 5, 2011
J.K. WallCarmel resident David Wasilewski has launched WhatNext, a website that uses algorithms to make it easier
for cancer patients to connect with others in similar circumstances. Wasilewski, 39, spent eight years as chief operating
officer of the Spanx line of body shapers and did health care consulting before that. In addition to helping patients, he
thinks WhatNext can become a way for health care organizations share their expertise with patients in need.
MoreTakeda, Lilly may face thousands of suits over Actos claims
December 1, 2011
Bloomberg NewsTakeda Pharmaceutical Co. and marketing co-partner Eli Lilly and Co. may face as many as 10,000 lawsuits in U.S. courts over
allegations that their Actos diabetes drug causes bladder cancer.
MoreWellPoint won’t put brand-name Lipitor on generics list
December 1, 2011
Bloomberg NewsIndianapolis-based WellPoint Inc., the largest U.S. health insurer by enrollment, will favor a copy of the blockbuster cholesterol
medication made by Watson Pharmaceuticals Inc., the insurer said.
MoreDrugmakers, pharmacists at odds
November 28, 2011
J.K. WallIndianapolis-based Eli Lilly and Co. recently rejected CVS Caremark’s demands for big price discounts on its insulins,
leading CVS to kick Lilly’s insulins off its list of recommended drugs.
MoreDecatur Vein Clinic branches out
November 26, 2011
J.K. WallIn little more than a decade, former Conseco director Dr. David Decatur has turned his single-office family practice into
a multistate chain of vein clinics. A 14th location is planned.
More
Sponsored by
ADVERTISEMENT
on Facebook & Twitter
on Facebook & Twitter
 Follow IBJ's Tweets on these topics: |
||
| @IBJNews | @Propertylines | @IBJTheScore |
| @IBJArts | @IBJHealthcare | @IBJDining |
| @IBJLists | @IBJSmallbiz | |
ADVERTISEMENT
Back to TopCopyright © All Rights Reserved. Privacy Policy | Terms of Use.
Design, CMS, Hosting & Web Development :: ePublishing.
Additional Hosting & Delivery by
liek the rest of America
These quaint,obsessed musings by the stalkers are certainly entertaining, but I'm trying to figure out what, if anything, all the yelping below has to do with Zak Brown.
It's evident that Moffett was pushing the right buttons and corporate America is now trying to squash him. He just wanted to withdraw the free pilot services provided to the company by the pilots to try and put some pressure on a company that has not been interested in negotiating a contract in over 5 years. The company does not provide a contract because not having one has saved them a bundle of money. Shame on any Republic pilots not standing behind their union leader just because things are getting tough, can you not see such strategic moves by the company as putting the last union president in a corporate position and into THEIR pocket. Do you really believe the last union president is so appalled at the attempts by Moffett, do you not remember his oppositions to the company? We stood behind him. It has been proven over and over again for thousands of years without fail, a man cannot serve two masters. Anyone that believes people vote contrary to their paycheck and livelihood deserve to be taken advantage of, the recent statements by the former union president are laughable as he denounces the current union president from his new corporate position. Have you ever seen a drafted sports player score points for his previous team, it cannot be done, he is not on the pilots side anymore, he gets his money a different way now than you and I do, and he should not be allowed to remain on the seniority list. A drafted player brings strength, credibility, tactical knowledge, and a strategic advantage to his NEW team, he would not be drafted or paid were it otherwise. We are all forced to choose only one side to play for and support, not doing so has many references in life such as insider trading and shaving points, all illegal for good reason. This basic fact is why corporate moguls, scientist, and engineers all sign non-discloser agreements and non-compete clauses, as protection in case they are lured into switching sides as our former union president has done. No NFL coach ever drafted a player so that both teams could benefit and better understand each other, they are recruited to win the game against that former team, period. Likewise the company does not recruit the former union president by accident or mutual understanding, its strategy. Don't confuse playing the game with good sportsman-like conduct in support of common business and prosperity goals, with the requirement to only play for one side. Good men we all love and favor fall subject to this manipulation, often without their knowledge, and it is not a betrayal of their friendship to oppose them when they switch sides. If we did not love and trust them, they would not have been chosen and lured to the other side in the first place. The deception by the drafted player is not made at a conscious level, it's just human nature and it's all about money and power which corrupts our ability to be objective and loyal to two masters. This is why our court system created the defense attorney, and why our military created counter intelligence. Its strategy and its propaganda, and it works, and that's why the "powers to be" manipulate the chess pieces by sometimes changing their colors. Some players know they are being manipulated when their color is changed, but it brings them more money and power so they do not care. The rest have good intentions but do not even realize they are being manipulated. This tactic is also known by another name, Divide and Conquer. In battle sending an imperfect message with an imperfect team is obviously not ideal, but it's still being sent by YOUR team, your union leader, a leader that has common goals and common rewards with you, they are the best, because we have elected them to do a job for us. If you are not backing Moffett but believing the spin by those that have recently switched sides, you are taking food out of your own mouth. Showing unity and backing an imperfect situation still results in taking just as much ground, it's about unity and bargaining power. It's not necessary to wait around for that perfect attack because it will never come, the company will spin and attempt to destroy anyone that gets in their way. Ultimately it's not about any specific attack anyway, ASAP or whatever it makes no difference, it is and always has been only about power. If this company cared about safety it would not build pairings with 8 hour overnights, come on, are you that naive? Besides, do you really think Hoffa cares, no, he got a call from corporate America and was squeezed into denouncing Moffett. If he didn't they would spin the safety card against him and the Teamsters National with implication for truckers, future contracts, insurance rates etc...saying something like the Teamsters use safety as a bargaining chip, blah blah blah... Do you really think any pilot is going to do something unsafe for the contract, absolutely not, the only ones threatening safety here is the company with reduced rest, fatigue, and poverty. Do you not find it odd that Hoffa and the Teamsters are opposing a Teamster president publicly? Would the Teamsters National not normally support and work with one of their own? Why did they not sit down and help him strategize, correct any mistakes, and charge ahead? Would the Teamsters National not normally support and leverage a contract for all those pilots that have been paying Teamster dues, isn't that why we have all been paying Teamster dues in the first place? I sure haven't been paying dues so that the Teamsters National could come along and write this kind of an article undercutting our union leader and our unity. Whose side is the Teamsters National really on, it's obviously not the Republic pilots side.
No matter what Moffatt does the company is going to spin it like he is the terrorist and brainwash people like you into believing it, wake up, back your players that are trying to change things for you and your livelihood. Where has Hoffa been for the last 6 years, except collecting our dues. Seriously, do you really think an FO going for upgrade, signed off by a checkairman ready for the upgrade, who then fails, is not even capable of returning as a First Officer.
whoa!